The WHO said in March 2021 that countries depending on the AstraZeneca vaccine from the Serum Institute of India, branded Covishield in India, would experience delays "due to the increased demand for COVID-19 vaccines in India"
Some 64 countries are due to receive COVID-19 vaccines from the World Health Organization's COVAX facility for low and middle income countries, but this has taken a hit